What does Brainreader do?
Brainreader is a medtech company based in Denmark that provides Neuroreader®, a CE-marked and FDA-cleared diagnostic platform which analyzes MRI brain scans by comparing measured brain volumes against an age and gender matched population, helping physicians arrive at more informed diagnoses.
How much did they raise?
The company raised €6.6m in a funding round led by Dahlgren Capital, with participation from existing investor Investo Capital.
What are their plans for the money?
Brainreader intends to use the funds to expand its commercial operations, which could lead to greater market penetration and further enhancements in its neurodiagnostic tools and integration within clinical workflows.
What have they achieved so far?
The company has already achieved significant regulatory milestones by securing CE-mark and FDA clearance, demonstrating the efficacy and reliability of its Neuroreader® platform.
